Le Lézard
Classified in: Health
Subject: PER

Renowned Expert to Lead Center for Diabetes & Metabolic Health


NEW YORK, Sept. 18, 2018 /PRNewswire/ -- Lauren H. Golden, MD, a nationally renowned clinician, has been appointed director of the Center for Diabetes & Metabolic Health at NYU Langone Health to augment the institution's efforts and reputation for excellence in diabetes care.

Dr. Lauren H. Golden, newly appointed Director of the Center for Diabetes & Metabolic Health at NYU Langone Health.

Dr. Golden is tasked with developing an acknowledged center of excellence in diabetes care by advancing care standards, building interdisciplinary clinical collaborations and broadening research efforts across NYU Langone's multiple inpatient and outpatient sites. Golden also will work to increase access to care and diabetes education, preventive services and telehealth options to not only make patients' lives easier, but also establish a more concrete infrastructure for the center.

Prior to joining NYU Langone, Dr. Golden served as an assistant professor of medicine and head of professional education at the Naomi Berrie Diabetes Center at Columbia University Medical Center.

"We're excited to welcome Dr. Golden to NYU Langone," says Ira J. Goldberg, MD, the Clarissa and Edgar Bronfman, Jr. Professor of Endocrinology and director of the Division of Endocrinology in the Department of Medicine at NYU Langone. "Her vast experience leading and bringing together comprehensive care teams will be invaluable to advancing our mission to advance diabetes care at our institution."

About Dr. Golden

After receiving her medical degree from the Mount Sinai Icahn School of Medicine, where she also completed her residency, Dr. Golden completed a clinical fellowship in endocrinology at the Yale School of Medicine and a fellowship in clinical investigation at Rockefeller University.

Her research and writing has been published in many peer-reviewed journals and textbooks including the American Journal of Pathology, EndoText, and Bone. Golden also has lectured at numerous professional society meetings, and she maintains active membership with the Endocrine Society and the American Diabetes Association.

"As a physician, it not only takes coordinated and multidisciplinary care to treat this chronic illness, but also takes collaboration with our patients to provide them with the best possible treatment plan and quality of life," Golden says. "That's why I'm thrilled to join an institution like NYU Langone that has seized the opportunity to advance care and access for its diabetes patients."

Diabetes Care at NYU Langone

NYU Langone's Center for Diabetes and Metabolic Health is dedicated to helping people with type 1 and type 2 diabetes manage their condition and prevent complications that can affect their health and quality of life. 

The Center's multidisciplinary care team is led by an endocrinologist who works closely with diabetes educators, nutritionists, nurses, nurse practitioners, and physician assistants to develop an individualized treatment plan for each patient. 

Clinical collaborations and standardized protocols are constantly developed and implemented across NYU Langone sites and programs to help treat diabetes patients at all points throughout their healthcare journey. For example, to address an often overlooked patient population, Golden and the Center's team will work alongside Mary Pat Gallagher, MD, Director of the Robert I. Grossman, MD, and Elisabeth J. Cohen, MD, Pediatric Diabetes Center, to develop a program addressing the transition of care for pediatric patients with Type 1 diabetes as they enter adulthood.

To also further enhance care, diabetes patients at NYU Langone also have access to clinical trials and cutting edge research. Other programs and centers available to patients include the Diabetes Prevention Program, the Weight Management Program, the Diabetes Foot and Ankle Center, and the Center for the Prevention of Cardiovascular Disease.

Media Inquiries:
Jamie Liptack
212-404-4279
[email protected]

NYU Langone Health logo (PRNewsFoto/NYU Langone Medical Center)

SOURCE NYU Langone Health


These press releases may also interest you

at 09:41
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...

at 09:30
PossibleNOWtm, the leading provider of enterprise consent and preference management solutions, today announced the launch of a program to enable companies to quickly capture express written consent. This will provide the ability for Third-Party...

at 09:30
Envisagenics, an AI-driven biotechnology company, today announced the publication in the journal Molecular Systems Biology of study results evaluating the company's SpliceCore AI/ML platform in Triple Negative Breast Cancer (TNBC). This study...

at 09:30
Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the...

at 09:20
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...



News published on and distributed by: